Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04975256
Title Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
The Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Next Oncology San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field